Item 8.01. Other Events
On
The presentation highlights the recent advancements Dyadic has made with its
C1-cell protein expression platform including the initiation of its first in
human Phase 1 program for an antigen expressed in the C1 platform, with the
trial expected to begin in early
Representatives of Dyadic will use the presentation in industry conferences, investor conferences and investor meetings from time to time. A copy of the press release is filed as Exhibit 99.1 and a copy of the presentation is also attached hereto as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits (d) Exhibits The following exhibit is being furnished herein: Exhibit Number Description 99.1 Dyadic International Press Release DatedJanuary 4, 2023 99.2 Dyadic International Presentation, "Next Generation Proteins forWorld Health ", datedJanuary 4, 2023 104 Cover page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source